Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab [5]

Dermatology

Volumn 216, Issue 2, 2008, Pages 185-186

  Fabre, C ^a   Dereure, O ^a,b  

^a UNIV MONTPELLIER   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Alopecia areata; Halo nevus; Infliximab

Indexed keywords

INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALOPECIA AREATA; ANKYLOSING SPONDYLITIS; CASE REPORT; DRUG SUBSTITUTION; HAIR LOSS; HUMAN; HYPOPIGMENTATION; LETTER; MALE; NEVUS; PRIORITY JOURNAL;

ADULT; ALOPECIA AREATA; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NEVUS, PIGMENTED; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38549118358     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111523     Document Type: Letter

References (7)

1. Tosti A, Pazzaglia M, Starace M, Bellavista S, Vincenzi C, Tonelli G: Alopecia areata during treatment with biologic agents. Arch Dermatol 2006;42:1653-1654.
2. Garcia Bartels N, Lee HH, Worm M, Burmester GR, Sterry W, Blum-Peytavi U: Development of alopecia areata universalis in a patient receiving adalimumab. Arch Dermatol 2006;142:1654-1655.
3. Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P: Autoimmunity and anti-TNF-alpha agents. Ann NY Acad Sci 2005;1051:559-569.
4. Ettefagh L, Nedorost S, Mirmirani P: Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles. Arch Dermatol 2004;140:1012.
5. Posten W, Swan J: Recurrence of alopecia areata in a patient receiving etanercept injections. Arch Dermatol 2005;141:759-760.
6. Rigopoulos D, Gregoriou S, Larios G, Moustou E, Belayeva-Karatza E, Kalogeromitros D: Etanercept in the treatment of vitiligo. Dermatology 2007;215:84-85.
7. Ramirez-Hernandez M, Marras C, Martinez-Escribano JA: Infliximab-induced vitiligo. Dermatology 2005;210:79-80.